Literature DB >> 9234486

Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus.

J Eskdale1, P Wordsworth, S Bowman, M Field, G Gallagher.   

Abstract

Recent studies have shown elevated IL-10 levels in several rheumatic autoimmune diseases, and particularly in systemic lupus erythematosus (SLE). Such changes may have a genetic basis. We studied two novel polymorphic dinucleotide repeats in the IL-10 promoter region (IL10.G and IL10.R) in order to investigate their possible significance in association with this condition in a group of 56 Caucasian SLE patients compared with 102 ethnically matched controls. The results show that there is an allelic imbalance between SLE patients and controls at the IL10.G microsatellite; this observation is supported by a significant difference in genotype distribution. The nature of autoantibody production and the presence or absence of renal involvement also appeared to be associated with certain IL10.G microsatellite alleles, although the small size of individual clinical sub-groupings may have influenced this result. No association with the IL10.R microsatellite was observed. Overall, the differences observed at the IL10.G microsatellite between SLE patients and controls suggest that the IL-10 locus contributes to the genetic background important for the development of this disease. Although the moderate sample size described in this study requires that the results be interpreted carefully, they provide an interesting and useful framework for future study.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9234486     DOI: 10.1111/j.1399-0039.1997.tb02812.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  36 in total

Review 1.  Cytokines and systemic lupus erythematosus.

Authors:  G S Dean; J Tyrrell-Price; E Crawley; D A Isenberg
Journal:  Ann Rheum Dis       Date:  2000-04       Impact factor: 19.103

Review 2.  Candidate gene case-control association studies: advantages and potential pitfalls.

Authors:  A K Daly; C P Day
Journal:  Br J Clin Pharmacol       Date:  2001-11       Impact factor: 4.335

3.  Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-/-) mice.

Authors:  Sander I van Leuven; Yanice V Mendez-Fernandez; Ashley J Wilhelm; Nekeithia S Wade; Curtis L Gabriel; John J Kastelein; Erik S Stroes; Paul P Tak; Amy S Major
Journal:  Ann Rheum Dis       Date:  2011-09-27       Impact factor: 19.103

4.  Association of apoptosis-related microsatellite polymorphisms on chromosome 1q in Taiwanese systemic lupus erythematosus patients.

Authors:  J-Y Chen; C-M Wang; S-C Lu; Y-H Chou; S-F Luo
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

5.  Associations between interleukin-10 polymorphisms and susceptibility to psoriasis: a meta-analysis.

Authors:  Young Ho Lee; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Inflamm Res       Date:  2012-03-18       Impact factor: 4.575

Review 6.  Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease.

Authors:  Shankar Subramanian Iyer; Gehong Cheng
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

7.  Association of interleukin-10 promoter haplotypes with disease susceptibility and IL-10 levels in Mexican patients with systemic lupus erythematosus.

Authors:  Claudia Azucena Palafox-Sánchez; Edith Oregon-Romero; Diana Celeste Salazar-Camarena; Yeminia Maribel Valle; Jesús René Machado-Contreras; Alvaro Cruz; Mariana Orozco-López; Gerardo Orozco-Barocio; Mónica Vázquez-Del Mercado; José Francisco Muñoz-Valle
Journal:  Clin Exp Med       Date:  2014-09-25       Impact factor: 3.984

Review 8.  Cell type-specific regulation of IL-10 expression in inflammation and disease.

Authors:  Christian M Hedrich; Jay H Bream
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

Review 9.  IL-10 and TNFalpha genotypes in SLE.

Authors:  Patricia López; Carmen Gutiérrez; Ana Suárez
Journal:  J Biomed Biotechnol       Date:  2010-06-21

10.  Intereleukin-10 promoter polymorphism in mild cognitive impairment and in its clinical evolution.

Authors:  Beatrice Arosio; Luigina Mastronardi; Carlo Vergani; Giorgio Annoni
Journal:  Int J Alzheimers Dis       Date:  2010-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.